Financial statements Bioekob
Balance sheet data of BIOEKOB
Year
|
2021
|
2022
|
2023
|
---|---|---|---|
Total assets | 3 172 074,52 | 3 184 345,06 | 3 185 603,83 |
A. Fixed assets | 3 132 473,33 | 3 132 473,33 | 3 132 473,33 |
B. Current assets | 39 601,19 | 51 871,73 | 53 130,50 |
C. Share capital contributions (basic funds) | 0,00 | 0,00 | - |
D. Own shares (stocks) | 0,00 | 0,00 | - |
Total liabilities | 3 172 074,52 | 3 184 345,06 | 3 185 603,83 |
A. Equity | 2 449 157,35 | 2 536 375,55 | 2 668 595,04 |
B. Liabilities and provisions for liabilities | 722 917,17 | 647 969,51 | 517 008,79 |
I. Long-term liabilities | 454 166,32 | 454 166,32 | 342 384,40 |
II. Short-term liabilities | 268 750,85 | 193 803,19 | 173 624,39 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.